Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

NCT: NCT07183644 · RECRUITING

NCT IDNCT07183644
StatusRECRUITING
Start Date2026-07
Completion2028-09
SponsorUniversity of Texas Southwestern Medical Center (OTHER)
First posted
Last updated

Brief Summary

In this study the investigators aim to optimize Port-Wine-Birthmark (PBW) laser therapy in children in order to reduce the number of laser treatments required for clearance and improve outcomes for refractory cases. This approach also seeks to reduce the frequency with which children require general anesthesia for treatment.

Frequently Asked Questions

What is Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients?

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients is a clinical trial registered under NCT07183644. Current status: RECRUITING.

What is the status of NCT07183644?

The current status of NCT07183644 (Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients) is: RECRUITING.

When did Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients start?

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.